Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinicopathological, Genomic Characteristics and Prognostic Analysis in 18 Cases  of SMARCA4-deficient or SMARCA4-mutated Pulmonary Tumors].

Zhongguo fei ai za zhi = Chinese journal of lung cancer - 20 Mar 2026

Liu Chang, Yang Jing, Meng Fanlu, Zhang Linlin, Wang Xin, Yu Tao, Zhong Diansheng

Abstract excerpt

BACKGROUND: The diagnosis of SMARCA4-altered pulmonary tumors primarily relies on the detection of protein loss by immunohistochemistry (IHC). However, the concordance between IHC and genetic testing results, as well as the clinical and biological differences caused by various mutation types, require further investigation. This study aimed to explore the clinicopathological, genomic characteristics, as well as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Helicases

Share to Genomics

Share to Lung Neoplasms

Share to Nuclear Proteins

Share to Prognosis

Share to Transcription Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 42124413
DOI: 10.3779/j.issn.1009-3419.2026.106.09
PMCID: PMC13167991

Genes

SMARCA4
EGFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinicopathological, Genomic Characteristics and Prognostic Analysis in 18 Cases of SMARCA4-deficient or SMARCA4-mutated Pulmonary Tumors].PMID 42124413Read ↗

The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer.Semantic proximity Read ↗

Clinicopathological characteristics and treatment outcomes of advanced SMARCA4-deficient thoracic tumors.Semantic proximity Read ↗

Perspectives and Issues in the Assessment of SMARCA4 Deficiency in the Management of Lung Cancer Patients.Semantic proximity Read ↗

Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods.Semantic proximity Read ↗

[Clinicopathological features of SMARCA4-deficient lung adenocarcinoma: a study of 42 cases].Semantic proximity Read ↗

Clinicopathological characteristics and therapeutic outcomes in patients with non-small cell lung cancer harboring SMARCA4 mutations.Semantic proximity Read ↗

[Clinical characteristics and prognostic analysis of thoracic SMARCA4-deficient undifferentiated tumor].Semantic proximity Read ↗

[Research Progress on SMARCA4 Mutation Non-small Cell Lung Cancer].Semantic proximity Read ↗

SMARCA4-deficient thoracic malignancies with small cell lung cancer-like features: A clinicopathological and molecular study of a heterogeneous group.Semantic proximity Read ↗

SMARCA4 deficiency and mutations are frequent in large cell lung carcinoma and are prognostically significant.Semantic proximity Read ↗

Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4- deficent thoracic tumorsSemantic proximity Read ↗

Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.